Literature DB >> 18827194

Enhanced gamma interferon responses of mouse spleen cells following immunotherapy for tuberculosis relapse.

Olga Gil1, Cristina Vilaplana, Evelyn Guirado, Jorge Díaz, Neus Cáceres, Mahavir Singh, Pere-Joan Cardona.   

Abstract

Gamma interferon responses of spleen cells in mice were examined during postchemotherapy relapse of intraperitoneally induced latent tuberculous infection. The mycobacterial extract RUTI, which prevented the relapse, significantly enhanced the immune responses to secreted and structural recombinant mycobacterial antigens, suggesting that RUTI-mediated protection was mediated by activated T cells.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18827194      PMCID： PMC2583524          DOI： 10.1128/CVI.00255-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  7 in total

1.  The heat resistance of tubercle bacilli in the lungs of infected mice.

Authors:  J G WALLACE
Journal:  Am Rev Respir Dis       Date:  1961-06

2.  Replication dynamics of Mycobacterium tuberculosis in chronically infected mice.

Authors:  Ernesto J Muñoz-Elías; Juliano Timm; Tania Botha; Wai-Tsing Chan; James E Gomez; John D McKinney
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.

Authors:  P Andersen
Journal:  Scand J Immunol       Date:  1997-02       Impact factor: 3.487

4.  Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.

Authors:  Pere-Joan Cardona; Isabel Amat; Sergi Gordillo; Virginia Arcos; Evelyn Guirado; Jorge Díaz; Cristina Vilaplana; Gustavo Tapia; Vicenç Ausina
Journal:  Vaccine       Date:  2005-02-03       Impact factor: 3.641

5.  A mouse model for slowly progressive primary tuberculosis.

Authors:  T Mustafa; S Phyu; R Nilsen; R Jonsson; G Bjune
Journal:  Scand J Immunol       Date:  1999-08       Impact factor: 3.487

6.  Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.

Authors:  Evelyn Guirado; Olga Gil; Neus Cáceres; Mahavir Singh; Cristina Vilaplana; Pere-Joan Cardona
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

7.  Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.

Authors:  Andrea J Wolf; Ludovic Desvignes; Beth Linas; Niaz Banaiee; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal:  J Exp Med       Date:  2007-12-24       Impact factor: 14.307
  7 in total
  3 in total

Review 1.  Vaccine development for tuberculosis: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

2.  Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis.

Authors:  Cristina Vilaplana; Olga Gil; Neus Cáceres; Sergio Pinto; Jorge Díaz; Pere-Joan Cardona
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

Review 3.  Vaccines for TB: Lessons from the Past Translating into Future Potentials.

Authors:  Gee Jun Tye; Min Han Lew; Yee Siew Choong; Theam Soon Lim; Maria Elena Sarmiento; Armando Acosta; Mohd Nor Norazmi
Journal:  J Immunol Res       Date:  2015-06-03       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.